These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33604753)

  • 1. Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis.
    Shen Z; Gu X; Cao H; Mao W; Yang L; He M; Zhang R; Zhou Y; Liu K; Wang L; Liu L; Yu J; Yin L
    Int Microbiol; 2021 May; 24(2):263-273. PubMed ID: 33604753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis.
    Rajagopala SV; Yooseph S; Harkins DM; Moncera KJ; Zabokrtsky KB; Torralba MG; Tovchigrechko A; Highlander SK; Pieper R; Sender L; Nelson KE
    BMC Genomics; 2016 Aug; 17(1):635. PubMed ID: 27527070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.
    Galloway-Peña JR; Smith DP; Sahasrabhojane P; Wadsworth WD; Fellman BM; Ajami NJ; Shpall EJ; Daver N; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
    Genome Med; 2017 Feb; 9(1):21. PubMed ID: 28245856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia.
    Robinson S; Peterson CB; Sahasrabhojane P; Ajami NJ; Shelburne SA; Kontoyiannis DP; Galloway-Peña JR
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy.
    Chua LL; Rajasuriar R; Lim YAL; Woo YL; Loke P; Ariffin H
    BMC Cancer; 2020 Feb; 20(1):151. PubMed ID: 32093640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia.
    Hakim H; Dallas R; Wolf J; Tang L; Schultz-Cherry S; Darling V; Johnson C; Karlsson EA; Chang TC; Jeha S; Pui CH; Sun Y; Pounds S; Hayden RT; Tuomanen E; Rosch JW
    Clin Infect Dis; 2018 Aug; 67(4):541-548. PubMed ID: 29518185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
    Rattanathammethee T; Tuitemwong P; Thiennimitr P; Sarichai P; Na Pombejra S; Piriyakhuntorn P; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Tantiworawit A; Norasetthada L
    PLoS One; 2020; 15(10):e0236460. PubMed ID: 33112882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota.
    De Pietri S; Ingham AC; Frandsen TL; Rathe M; Krych L; Castro-Mejía JL; Nielsen DS; Nersting J; Wehner PS; Schmiegelow K; Hasle H; Pamp SJ; Müller K
    Int J Cancer; 2020 Oct; 147(7):1953-1962. PubMed ID: 32115690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Microbiomes of Gut and Saliva in Patients With Systemic Lupus Erythematous and Clinical Associations.
    Liu F; Ren T; Li X; Zhai Q; Xu X; Zhang N; Jiang P; Niu Y; Lv L; Shi G; Feng N
    Front Immunol; 2021; 12():626217. PubMed ID: 34276643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-Level Salivary Microbial Indicators of Well-Resolved Periodontitis: A Preliminary Investigation.
    Acharya A; Chen T; Chan Y; Watt RM; Jin L; Mattheos N
    Front Cell Infect Microbiol; 2019; 9():347. PubMed ID: 31681625
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of blood on the human gut microbiome.
    Chénard T; Malick M; Dubé J; Massé E
    BMC Microbiol; 2020 Mar; 20(1):44. PubMed ID: 32126968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Health, Caries Risk Profiles, and Oral Microbiome of Pediatric Patients with Leukemia Submitted to Chemotherapy.
    Wang Y; Zeng X; Yang X; Que J; Du Q; Zhang Q; Zou J
    Biomed Res Int; 2021; 2021():6637503. PubMed ID: 33532491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia.
    Rashidi A; Kaiser T; Shields-Cutler R; Graiziger C; Holtan SG; Rehman TU; Wasko J; Weisdorf DJ; Dunny G; Khoruts A; Staley C
    Sci Rep; 2019 Apr; 9(1):6083. PubMed ID: 30988420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
    Galloway-Peña JR; Smith DP; Sahasrabhojane P; Ajami NJ; Wadsworth WD; Daver NG; Chemaly RF; Marsh L; Ghantoji SS; Pemmaraju N; Garcia-Manero G; Rezvani K; Alousi AM; Wargo JA; Shpall EJ; Futreal PA; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
    Cancer; 2016 Jul; 122(14):2186-96. PubMed ID: 27142181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota.
    Stewardson AJ; Gaïa N; François P; Malhotra-Kumar S; Delémont C; Martinez de Tejada B; Schrenzel J; Harbarth S; Lazarevic V;
    Clin Microbiol Infect; 2015 Apr; 21(4):344.e1-11. PubMed ID: 25658522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the intestinal microbiota composition and the effect of treatment with intensive chemotherapy in patients recovered from acute leukemia.
    Vázquez X; Lumbreras-Iglesias P; Rodicio MR; Fernández J; Bernal T; Moreno AF; de Ugarriza PL; Fernández-Verdugo A; Margolles A; Sabater C
    Sci Rep; 2024 Mar; 14(1):5585. PubMed ID: 38454103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the Oral and Gastrointestinal Microbiomes to Bloodstream Infections in Leukemia Patients.
    McMahon S; Sahasrabhojane P; Kim J; Franklin S; Chang CC; Jenq RR; Hillhouse AE; Shelburne SA; Galloway-Peña J
    Microbiol Spectr; 2023 Jun; 11(3):e0041523. PubMed ID: 37022173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.